QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...oup Plc (LSE: PSK.L) Solvay S.A. (Brussels: SVYSY) Add Altus Pharmaceuticals Inc. (Nasdaq: ALTU ) Amicus Therapeutics, Inc. (Nasdaq: FOLD ) biodel Inc. (Nasdaq: BIOD ) CombinatoRx Inc. (Nasdaq: CRXX ) GW Pharmaceuticals Plc (LSE: GWP.L) Incyte Corp. (Nasdaq: INCY ) Orexigen Therapeutic...Biodel Inc. to Present at 26th Annual JPMorgan Healthcare Conference on January 7th, 2008
... DANBURY, Conn., Dec. 21 /PRNewswire-FirstCall/ -- biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solom...ailable at the same locations for 14 days. About biodel Inc. biodel Inc. is a specialty biopharmaceutical company focu...Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results
... DANBURY, Conn., Dec. 11 /PRNewswire-FirstCall/ -- biodel Inc. (Nasdaq: BIOD) today reported fourth quarter ... Fourth Quarter and Full Year Financial Results biodel reported a net loss for the fourth quarter ended S...cise of warrants at a discounted exercise price. biodel reported no revenue during the three months and ye...Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer
... DANBURY, Conn., Nov. 14 /PRNewswire-FirstCall/ -- biodel Inc. (Nasdaq: BIOD) today announced that Gerard Mi...an M.B.A., both from the University of Rochester. biodel also announced today that F. Scott Reding, the Com.... Reding played an important role in the growth of biodel and we thank him for his efforts on behalf of the ...Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
...DANBURY, Conn., Sept. 21 /PRNewswire-FirstCall/ -- biodel Inc. (Nasdaq: BIOD) today announced that the Compa...iority in terms of HbA1c levels and safety. About biodel Inc. biodel Inc. is a specialty biopharmaceutical company focu...Biodel Inc. to Present VIAject Clinical Progress at the 2007 American Diabetes Association Meeting
...resentation will be available for 14 days. About biodel Inc. biodel Inc. is a development stage specialty biopharmaceu...both of Burns McClellan, Inc.,+1-212-213-0006, for biodel Inc. biodel with strong internal clinical and regulatory leade... Hospital in endocrinology and metabolism. About biodel Inc. ...Biodel Inc. Added to NASDAQ Biotechnology Index
... DANBURY, Conn., May 13 /PRNewswire-FirstCall/ -- biodel Inc. (Nasdaq: BIOD) today announced that the Compa...y criteria, visit http://www.nasdaq.com . About biodel Inc. biodel Inc. is a specialty biopharmaceutical company focu...Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
... DANBURY, Conn., May 9 /PRNewswire-FirstCall/ -- biodel Inc. (Nasdaq: BIOD) today reported financial resul...mic events." Three Months Ended March 31, 2008 biodel reported no revenue during the three months ended March 31, 2008 and March 31, 2007. biodel reported a net loss for the three months ended Mar...Biodel Inc. to Present at the Bank of America 2008 Health Care Conference on May 13th 2008
... DANBURY, Conn., May 5 /PRNewswire-FirstCall/ -- biodel Inc. (Nasdaq: BIOD) today announced that Gerard Mi...on will be available at the same location. About biodel Inc. biodel Inc. is a specialty biopharmaceutical company focu...Biodel Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference April 30th 2008
...DANBURY, Conn., April 22 /PRNewswire-FirstCall/ -- biodel Inc. (Nasdaq: BIOD) today announced that Dr. Solom...on will be available at the same location. About biodel Inc. biodel Inc. is a specialty biopharmaceutical company focu...Biodel Inc. to Present at the BioCentury Future Leaders Conference on March 27th, 2008
...DANBURY, Conn., March 20 /PRNewswire-FirstCall/ -- biodel Inc. (Nasdaq: BIOD) today announced that Gerard Mi...on will be available at the same location. About biodel Inc. biodel Inc. is a specialty biopharmaceutical company focu...Biodel Inc. Reports First Quarter Fiscal Year 2008 Financial Results
... DANBURY, Conn., Feb. 14 /PRNewswire-FirstCall/ -- biodel Inc. (Nasdaq: BIOD) today reported financial resul...quarter." Three Months Ended December 31, 2007 biodel reported a net loss for the first quarter ended De...5 million of stock- based compensation expenses. biodel reported no revenue during the three months ended ...